Prevalence of Infection with the Hepatitis C Virus among Italian Hemophiliacs before and after the Introduction of Virally Inactivated Clotting Factor Concentrates: A Retrospective Evaluation
- 1 August 1994
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 67 (2) , 178-182
- https://doi.org/10.1111/j.1423-0410.1994.tb01655.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical Evaluation of Viral Safety of Coagulation Factor VIII and IX ConcentratesVox Sanguinis, 1993
- Evaluation of Antibodies to Hepatitis C Virus in a Study of Transfusion-Associated HepatitisNew England Journal of Medicine, 1990
- Hepatitis C antibody and chronic liver disease in haemophiliaThe Lancet, 1990
- High Prevalence of Antibody to Hepatitis C Virus in Multitransfused Hemophiliacs with Normal Transaminase LevelsAnnals of Internal Medicine, 1990
- ANTIBODIES TO HEPATITIS C VIRUS IN HAEMOPHILIAThe Lancet, 1989
- Heated Clotting Factors and Seroconversion for Human Immunodeficiency Virus in Three Hemophilic PatientsAnnals of Internal Medicine, 1987
- No Hepatitis After Treatment with a Modified Factor IX Concentrate in Previously Untreated HemophiliacsAnnals of Internal Medicine, 1985
- TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATEThe Lancet, 1985
- Life expectancy of Swedish haemophiliacs, 1831–1980British Journal of Haematology, 1985
- AN OUTBREAK OF HEPATITIS ASSOCIATED WITH INTRAVENOUS INJECTION OF FACTOR-VIII CONCENTRATEThe Lancet, 1975